...
首页> 外文期刊>BMC Cardiovascular Disorders >Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial
【24h】

Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial

机译:基于团队的协作护理对慢性冠心病的二级预防患者的疗效(教学):多中心随机对照试验的研究方案

获取原文
           

摘要

Coronary heart disease (CHD) is the leading cause of death and years of life lost worldwide. While effective treatments are available for both acute and chronic disease stages there are unmet needs for effective interventions to support patients in health behaviors required for secondary prevention. Psychosocial distress is a common comorbidity in patients with CHD and associated with substantially reduced health-related quality of life (HRQoL), poor health behavior, and low treatment adherence. In a confirmatory, randomized, controlled, two-arm parallel group, multicenter behavioral intervention trial we will randomize 440 distressed CHD patients with at least one insufficiently controlled cardiac risk factor to either their physicians' usual care (UC) or UC plus 12-months of blended collaborative care (TeamCare?=?TC). Trained nurse care managers (NCM) will proactively support patients to identify individual sources of distress and risk behaviors, establish a stepwise treatment plan to improve self-help and healthy behavior, and actively monitor adherence and progress. Additional e-health resources are available to patients and their families. Intervention fidelity is ensured by a treatment manual, an electronic patient registry, and a specialist team regularly supervising NCM via videoconferences and recommending protocol and guideline-compliant treatment adjustments as indicated. Recommendations will be shared with patients and their physicians who remain in charge of patients’ care. Since HRQoL is a recommended outcome by both, several guidelines and patient preference we chose a?≥?50% improvement over baseline on the HeartQoL questionnaire at 12?months as primary outcome. Our primary hypothesis is that significantly more patients receiving TC will meet the primary outcome criterion compared to the UC group. Secondary hypotheses will evaluate improvements in risk factors, psychosocial variables, health care utilization, and durability of intervention effects over 18–30?months of follow-up. TEACH is the first study of a blended collaborative care intervention simultaneously addressing distress and medical CHD risk factors conducted in cardiac patients in a European health care setting. If proven effective, its results can improve long-term chronic care of this vulnerable patient group and may be adapted for patients with other chronic conditions. Trial registration: German Clinical Trials Register, DRKS00020824, registered on 4 June, 2020; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00020824
机译:冠心病(CHD)是全世界死亡和生活年代的主要原因。虽然有效治疗可用于急性和慢性疾病阶段,但有效干预措施的有效需求,以支持二次预防所需的健康行为患者。心理社会窘迫是CHD患者的常见合并症,并且与大大降低的健康相关的生活质量(HRQOL),健康行为差和低治疗依从性相关。在确认,随机的,受控的双臂并联组中,我们将随机化440名患CHD患者,至少有一个不充分控制的心脏风险因素,以至于其医生通常护理(UC)或UC加12个月混合的协作护理(TeamCare?=?TC)。经过培训的护理管理人员(NCM)将积极支持患者确定个体遇险和风险行为的来源,建立一个逐步治疗计划,以改善自助和健康的行为,并积极监督依从性和进展。患者及其家庭可获得额外的电子健康资源。治疗手册,电子患者登记中心和经常监督NCM的专业团队确保干预保真度通过视频会议和标准的协议和指南兼容的处理调整。建议将与持续负责患者护理的患者及其医生分享。由于HRQOL是一部推荐的结果,我们选择了几种指南和患者偏好,我们选择了一个?≥?50%的基线在12?月份的基线上改进了12?数月作为主要结果。我们的主要假设是,与UC组相比,接受TC的患者显着更多的患者将符合主要结果标准。二次假设将评估风险因素,心理社会变量,保健利用以及18-30多个月的干预效果的耐用性的改善。教导是同时解决心脏病患者在欧洲医疗环境中进行的痛苦和医疗CHD危险因素进行混合的协作护理干预的第一次研究。如果证明有效,其结果可以改善这种脆弱的患者组的长期慢性护理,并且可以适用于其他慢性病症的患者。审判注册:德国临床试验登记,DRKS00020824,在2020年6月4日注册; https://www.drks.de/drks_web/navigate.do?wavigationId=trial.html&trial_id=drks00020824.
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号